New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
May 27, 2014
08:31 EDTAGNAllergan upgraded to Buy from Neutral at Buckingham
Buckingham upgraded Allergan (AGN) to Buy and raised its price target to $207 from $180 ahead of Valeantís (VRX) meeting Wednesday which should result in a higher bid for the company. The $207 price target reflects a higher stand-alone valuation for the company and potential balance sheet value enhancement moves.
News For AGN From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
May 15, 2015
10:29 EDTAGNAmerican Urological Association to hold an annual meeting
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use